2013 Fiscal Year Final Research Report
Establishment of new therapeutic protocol for pediatric renal tumor according to the new risk classification
Project/Area Number |
23390405
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Pediatric surgery
|
Research Institution | Osaka University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
OUE Takaharu 大阪大学, 医学部, 講師 (50314315)
金子 安比古 埼玉県立がんセンター臨床腫瘍研究所, 研究所長 (50373387)
野崎 美和子 獨協医科大学越谷病院, 放射線科, 教授 (30197727)
大喜多 肇 国立成育医療研究センター研究所, 室長 (50317260)
樋之津 史郎 岡山大学病院, 新医療研究開発センター, 教授 (80323567)
|
Project Period (FY) |
2011-04-01 – 2014-03-31
|
Keywords | 小児腎腫瘍 / 予後因子 / RASSF1A遺伝子 / WTX遺伝子 / 両側性腎芽腫 / 腎機能障害 / 治療プロトコール / 腎ラブドイド腫瘍 |
Research Abstract |
We analyzed methylation status of tumor suppressor gene RASSF1A in 84 Wilms tumors and found out that it was significantly associated with a poor outcome. Moreover, we analyzed the mutation of WTX gene and revealed that this also was significantly associated with a poor outcome. Therefore these biomarkers were considered be candidates of the new biomarkers for risk classification to create the new therapeutic protocols. The survival rate of bilateral Wilms tumors (BWT) has been improved; however, the results are not satisfactory in terms of the renal preservation. We reviewed the outcome of BWT registered in JWiTS. Bilateral nephron-sparing surgery (NSS) was achieved only in 10 of 28 cases (36%) and 10 children (40%) developed impaired renal function. The protocol should be changed to improve the rate of preservation of the renal parenchyma. Preoperative chemotherapy should be performed to shrink the tumors, and subsequent NSS should be carried out after a central imaging evaluation.
|
Research Products
(26 results)
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Bilateral Wilms' tumors treated according to the Japan Wilms Tumor Study Group protocol2013
Author(s)
Oue T, Fukuzawa M, Okita H, HorieH, Saito M, Nozaki M, Chin M, Nakadate N, Hinotsu S, Koshinaga T, Kaneko Y, Tanaka Y
Organizer
45th Congress of the International Society of Paediatric Oncology
Place of Presentation
Hong Kong, China
Year and Date
20130000
-
[Presentation] 日本ウィルムス腫瘍研究グループに登録された両側性腎芽腫の検討2013
Author(s)
大植孝治, 福澤正洋, 越永従道, 大喜多肇, 金子安比古, 堀江 弘, 斉藤正博, 野崎美和子, 陳 基明, 中館尚也, 樋之津史郎, 田中祐吉, 春田雅之, 桑島成子, 高安 肇
Organizer
第55回日本小児血液・がん学会
Place of Presentation
福岡
Year and Date
20130000
-
-
[Presentation] Current Results the Japan Wilms Tumor Study (JWiTS) and Future Protocols2012
Author(s)
Oue T, Fukuzawa M, Okita H, Mugishima H, Horie H, Hata J, Saito M, Nozaki M, Chin M, Nakadate N, Hinotsu S, Koshinaga T, KanekoY, Kitano K, Tanaka Y
Organizer
第54回日本小児血液・がん学会学術集会
Place of Presentation
横浜
Year and Date
20120000
-
-
-
[Presentation] がん抑制遺伝子RASSF1A のプロモーターメチル化はWilms 腫瘍の予後不良因子である2011
Author(s)
大島淳二郎, 春田雅之, 渡辺直樹, 新井康仁, 寺下友佳代, 長祐子, 井口晶裕, 有賀正, 大喜多肇, 越永従道, 大植孝治, 樋之津史郎, 中舘尚也, 堀江弘, 福澤正洋, 金子安比古
Organizer
第53回日本小児血液・がん学会学術集会
Place of Presentation
ベイシア文化ホール(群馬県)
Year and Date
20111124-27
-
[Presentation] 日本におけるWT1 遺伝子変異を有するウィルムス腫瘍の臨床病理学的検討2011
Author(s)
大喜多肇, 秦順一, 柴田理恵, 高田礼子, 菊池春人, 藤本純一郎, 金子安比古, 堀江弘, 田中祐吉, 福澤正洋, 清河信敬
Organizer
第100回日本病理学会総会
Place of Presentation
パシフィコ横浜(神奈川県)
Year and Date
20110428-30
-
-
-
-
[Book] 系統小児外科学第3版(福澤正洋, 中村哲郎, 窪田昭男編), 病理組織検査法, 分子標的治療, 再生医療, 腎芽腫, 肝腫瘍, 横紋筋肉腫, 膵腫瘍, 悪性リンパ腫2013
Author(s)
大植孝治
Total Pages
(72-74, 327-330, 331-336, 712-718, 719-729, 730-736, 743-746, 754-756)
Publisher
永井書店
-
-
-